Therapeutic Ionizing Radiation Induced Bone Loss: a Review of in Vivo and in Vitro Findings.

Jian Zhang,Xinyu Qiu,Kedi Xi,Wentao Hu,Hailong Pei,Jing Nie,Ziyang Wang,Jiahan Ding,Peng Shang,Bingyan Li,Guangming Zhou
DOI: https://doi.org/10.1080/03008207.2018.1439482
2018-01-01
Connective Tissue Research
Abstract:Radiation therapy is one of the routine treatment modalities for cancer patients. Ionizing radiation (IR) can induce bone loss, and consequently increases the risk of fractures with delayed and nonunion of the bone in the cancer patients who receive radiotherapy. The orchestrated bone remodeling can be disrupted due to the affected behaviors of bone cells, including bone mesenchymal stem cells (BMSCs), osteoblasts and osteoclasts. BMSCs and osteoblasts are relatively radioresistant compared with osteoclasts and its progenitors. Owing to different radiosensitivities of bone cells, unbalanced bone remodeling caused by IR is closely associated with the dose absorbed. For doses less than 2 Gy, osteoclastogenesis and adipogenesis by BMSCs are enhanced, while there are limited effects on osteoblasts. High doses (>10 Gy) induce disrupted architecture of bone, which is usually related to decreased osteogenic potential. In this review, studies elucidating the biological effects of IR on bone cells (BMSCs, osteoblasts and osteoclasts) are summarized. Several potential preventions and therapies are also proposed.
What problem does this paper attempt to address?